Filling a gap that pharma fails to fund, a new initiative will develop vaccines to prevent outbreaks of emerging viruses.
Her death is a reminder that antibiotic-resistant bacteria are getting worse, even as they garner little attention.
A startup called Ambrosia will fill your veins with the blood of young people and empty your pockets of $8,000.
Experts warn that a potential IVF breakthrough could have unintended social consequences.
When Brian Hanley set out to test a gene therapy, he started with himself.
The technique could be faster and more versatile than developing genetically modified crops from scratch.
Grail, a company that aims to use a blood test to spot cancer, has announced a massive round of funding for its experimental approach.
Nobel Prize winners lend their faces, credibility, to supplement maker Elysium’s advertising campaign.
A vaccine against the deadly virus has passed a key testing milestone, but it’s not a long-term solution to stop it.
Researchers have tested a modified malaria parasite in humans that has been shown to be safe and to trigger an immune response.